CRP and neoplasm: There were no significant differences in the demographics and clinical characteristics between the CRP-high and -low groups with the exception of AFP levels > 400 ng/L (CRP-high vs. -low groups = 71.4% vs. 47.9%, P = 0.034), WBC count >10×109/L (17.9% vs. 2.7%, P = 0.025), NLR ≥ 3 (71.4% vs. 31.5%, P = 0.001), and tumor size > 5 cm (78.6% vs. 41.1%, P = 0.001).